iCoreConnect Inc. (ICCT)
USD 2.34
(-17.61%)
USD 2.34
(-17.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.55 Million USD | -111.37% |
| 2022 | -7.35 Million USD | -26.8% |
| 2021 | -5.8 Million USD | -57.67% |
| 2020 | -3.68 Million USD | -16.65% |
| 2019 | -3.15 Million USD | 55.95% |
| 2018 | -7.16 Million USD | -59.51% |
| 2017 | -4.49 Million USD | 0.0% |
| 2014 | 1.95 Million USD | 126.96% |
| 2013 | -7.24 Million USD | -57.89% |
| 2012 | -4.58 Million USD | 8.6% |
| 2011 | -5.02 Million USD | 52.91% |
| 2010 | -10.66 Million USD | -31.51% |
| 2009 | -8.1 Million USD | -26.42% |
| 2008 | -6.41 Million USD | -37.23% |
| 2007 | -4.67 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -10.89 Million USD | -130.69% |
| 2024 Q1 | -4.72 Million USD | 36.72% |
| 2023 FY | -15.55 Million USD | -111.37% |
| 2023 Q3 | -3.69 Million USD | -36.35% |
| 2023 Q4 | -7.46 Million USD | -102.16% |
| 2023 Q2 | -2.7 Million USD | -18.5% |
| 2023 Q1 | -2.28 Million USD | -29.05% |
| 2022 Q2 | -1.56 Million USD | 24.85% |
| 2022 Q1 | -2.08 Million USD | -4186.34% |
| 2022 FY | -7.35 Million USD | -26.8% |
| 2022 Q4 | -1.77 Million USD | -1.94% |
| 2022 Q3 | -1.73 Million USD | -10.69% |
| 2021 Q2 | -302.05 Thousand USD | 62.84% |
| 2021 Q1 | -812.91 Thousand USD | 24.75% |
| 2021 FY | -5.8 Million USD | -57.67% |
| 2021 Q4 | 51.09 Thousand USD | 104.62% |
| 2021 Q3 | -1.1 Million USD | -266.08% |
| 2020 Q4 | -1.08 Million USD | -39.57% |
| 2020 Q2 | -857 Thousand USD | -9.87% |
| 2020 FY | -3.68 Million USD | -16.65% |
| 2020 Q1 | -780 Thousand USD | -8.03% |
| 2020 Q3 | -774 Thousand USD | 9.68% |
| 2019 Q1 | -761 Thousand USD | -9.34% |
| 2019 Q3 | -744 Thousand USD | 1.59% |
| 2019 Q4 | -722 Thousand USD | 2.96% |
| 2019 FY | -3.15 Million USD | 55.95% |
| 2019 Q2 | -756 Thousand USD | 0.66% |
| 2018 Q1 | -2.3 Million USD | -116.67% |
| 2018 Q4 | -696 Thousand USD | -12.99% |
| 2018 Q3 | -616 Thousand USD | 60.96% |
| 2018 Q2 | -1.57 Million USD | 31.39% |
| 2018 FY | -7.16 Million USD | -59.51% |
| 2017 Q4 | -1.06 Million USD | -80.53% |
| 2017 Q2 | -1.15 Million USD | 0.9% |
| 2017 Q1 | -1.16 Million USD | 0.0% |
| 2017 FY | -4.49 Million USD | 0.0% |
| 2017 Q3 | -588 Thousand USD | 49.13% |
| 2015 Q1 | -959.63 Thousand USD | -12.3% |
| 2014 FY | 1.95 Million USD | 126.96% |
| 2014 Q2 | -116.72 Thousand USD | -115.42% |
| 2014 Q1 | -54.18 Thousand USD | 90.02% |
| 2014 Q4 | -854.51 Thousand USD | 58.26% |
| 2014 Q3 | -2.04 Million USD | -1653.94% |
| 2013 Q3 | 2.66 Million USD | 135.79% |
| 2013 Q4 | -542.68 Thousand USD | -120.35% |
| 2013 FY | -7.24 Million USD | -57.89% |
| 2013 Q1 | -7.28 Million USD | -853.93% |
| 2013 Q2 | 1.13 Million USD | 115.53% |
| 2012 Q3 | -331.13 Thousand USD | 88.1% |
| 2012 Q4 | -763.35 Thousand USD | -130.52% |
| 2012 FY | -4.58 Million USD | 8.6% |
| 2012 Q1 | -641.29 Thousand USD | -2.13% |
| 2012 Q2 | -2.78 Million USD | -333.87% |
| 2011 Q3 | -553.56 Thousand USD | 67.6% |
| 2011 Q1 | -940.66 Thousand USD | -23.84% |
| 2011 Q4 | -627.9 Thousand USD | -13.43% |
| 2011 Q2 | -1.7 Million USD | -81.62% |
| 2011 FY | -5.02 Million USD | 52.91% |
| 2010 FY | -10.66 Million USD | -31.51% |
| 2010 Q2 | -6.68 Million USD | -2225.44% |
| 2010 Q1 | -287.4 Thousand USD | 74.48% |
| 2010 Q4 | -759.61 Thousand USD | 52.87% |
| 2010 Q3 | -1.61 Million USD | 75.88% |
| 2009 Q4 | -1.12 Million USD | 56.94% |
| 2009 FY | -8.1 Million USD | -26.42% |
| 2009 Q3 | -2.61 Million USD | 44.51% |
| 2009 Q2 | -4.71 Million USD | -268.74% |
| 2009 Q1 | -1.27 Million USD | -31.52% |
| 2008 Q4 | -971.96 Thousand USD | 14.92% |
| 2008 Q3 | -1.14 Million USD | 62.92% |
| 2008 Q1 | -1.21 Million USD | 56.33% |
| 2008 Q2 | -3.08 Million USD | -153.54% |
| 2008 FY | -6.41 Million USD | -37.23% |
| 2007 Q2 | -2.17 Million USD | -136.09% |
| 2007 Q3 | -555.22 Thousand USD | 74.49% |
| 2007 FY | -4.67 Million USD | 0.0% |
| 2007 Q4 | -2.78 Million USD | -401.13% |
| 2007 Q1 | -921.84 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accolade, Inc. | -99.8 Million USD | 84.418% |
| Aclarion, Inc. | -4.91 Million USD | -216.646% |
| Aclarion, Inc. | -4.91 Million USD | -216.646% |
| Augmedix, Inc. | -19.17 Million USD | 18.879% |
| HeartBeam, Inc. | -14.63 Million USD | -6.234% |
| HeartBeam, Inc. | -14.63 Million USD | -6.234% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -190.367% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -190.367% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 89.941% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 89.941% |
| CareCloud, Inc. | -48.67 Million USD | 68.049% |
| CareCloud, Inc. | -48.67 Million USD | 68.049% |
| CareCloud, Inc. | -48.67 Million USD | 68.049% |
| Certara, Inc. | -55.35 Million USD | 71.907% |
| CareMax, Inc. | -683.34 Million USD | 97.724% |
| CareMax, Inc. | -683.34 Million USD | 97.724% |
| Definitive Healthcare Corp. | -202.38 Million USD | 92.316% |
| EUDA Health Holdings Limited | -10.03 Million USD | -54.905% |
| EUDA Health Holdings Limited | -10.03 Million USD | -54.905% |
| Forian Inc. | 11.1 Million USD | 240.021% |
| GoodRx Holdings, Inc. | -8.86 Million USD | -75.368% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 100.992% |
| Health Catalyst, Inc. | -118.14 Million USD | 86.837% |
| Healthcare Triangle, Inc. | -12.33 Million USD | -26.037% |
| HealthEquity, Inc. | 55.71 Million USD | 127.914% |
| HealthStream, Inc. | 15.21 Million USD | 202.226% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 168.877% |
| MSP Recovery, Inc. | -56.34 Million USD | 72.401% |
| Mangoceuticals, Inc. | -9.21 Million USD | -68.812% |
| National Research Corporation | 30.97 Million USD | 150.214% |
| Nutex Health, Inc. | -45.78 Million USD | 66.034% |
| Omnicell, Inc. | -20.37 Million USD | 23.658% |
| OneMedNet Corporation | -23.2 Million USD | 32.983% |
| OptimizeRx Corporation | -17.56 Million USD | 11.467% |
| Ontrak, Inc. | -27.92 Million USD | 44.299% |
| Ontrak, Inc. | -27.92 Million USD | 44.299% |
| Progyny, Inc. | 62.03 Million USD | 125.068% |
| Premier, Inc. | 119.54 Million USD | 113.009% |
| Privia Health Group, Inc. | 23.07 Million USD | 167.384% |
| R1 RCM Inc. | 3.3 Million USD | 571.263% |
| Renalytix Plc | -33.45 Million USD | 53.516% |
| Schrödinger, Inc. | 40.72 Million USD | 138.192% |
| Sharecare, Inc. | -128.49 Million USD | 87.897% |
| Sharecare, Inc. | -128.49 Million USD | 87.897% |
| SHL Telemedicine Ltd. | -7.05 Million USD | -120.403% |
| Simulations Plus, Inc. | 9.95 Million USD | 256.235% |
| SOPHiA GENETICS SA | -78.98 Million USD | 80.31% |
| Spok Holdings, Inc. | 15.66 Million USD | 199.27% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | 16.823% |
| TruBridge, Inc. | -45.78 Million USD | 66.036% |
| 10x Genomics, Inc. | -255.09 Million USD | 93.904% |
| Minerva Surgical, Inc. | -34.11 Million USD | 54.41% |
| GeneDx Holdings Corp. | -175.76 Million USD | 91.152% |
| GeneDx Holdings Corp. | -175.76 Million USD | 91.152% |
| SCWorx Corp. | -3.98 Million USD | -290.633% |
| Zhongchao Inc. | -11.33 Million USD | -37.189% |